Dysfunction of synaptic endocytic trafficking in Parkinson's disease

Area of Science:

• Neuroscience
• Cell Biology
• Genetics

Background:

• Parkinson's disease (PD) involves selective dopamine neuron degeneration, but causes remain unclear.
• Genetic studies link PD to over 20 PARK genes and 90 risk loci.
• Many identified genes are involved in synaptic vesicle recycling, especially clathrin-mediated endocytosis.

Purpose of the Study:

• To review cellular and molecular findings on PD-linked endocytic proteins.
• To explore the role of clathrin-mediated endocytosis in PD pathogenesis.
• To discuss potential therapeutic targets related to synaptic dysfunction in PD.

Main Methods:

• Review of cellular and molecular findings from PD-linked gene models (auxilin, synaptojanin 1).
• Analysis of genome-wide association studies identifying PD risk factors in endocytic pathways.
• Exploration of roles for common PD-related proteins (alpha-synuclein, Parkin, LRRK2) in synaptic endocytic trafficking.

Main Results:

• Models with mutations in auxilin (DNAJC6/PARK19) and synaptojanin 1 (SYNJ1/PARK20) show similar dopamine terminal pathology.
• These models exhibit defects in synaptic membrane trafficking, supporting genetic findings.
• Several clathrin-mediated endocytosis proteins and common PD-linked proteins are implicated in PD pathogenesis and synaptic endocytic trafficking.

Conclusions:

• Impaired synaptic vesicle recycling via clathrin-mediated endocytosis may be an early feature of PD.
• Dysfunction in endocytic pathways and synaptic trafficking contributes to PD pathogenesis.
• Understanding these mechanisms may reveal novel targets for early PD diagnosis and therapy.